Genetic Technologies Limited
Genetic Technologies Limited (GNTLF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GNTLF · as of Jun 8, 2026
Key Statistics
Explore Genetic Technologies Limited Data
gntlf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 0.0%
Competitors & Peers
gntlf competitorsGNTLF
CHIZF
CMOPF
CSPHF
EVOTF
MRCHFStock Performance
Full HistoryAbout Genetic Technologies Limited
Genetic Technologies Limited a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company…
what is genetic technologies limited · gntlf stock overview · genetic technologies limited company profile · who is genetic technologies limited ceo · gntlf OTC · genetic technologies limited headquarters · genetic technologies limited business segments
About Stock Overview & Key Data
Genetic Technologies Limited (GNTLF) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on OTC since Oct 19, 2000. As of the latest trading session, GNTLF stock price is $1.00, with a market capitalization of $1.3B. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Genetic Technologies Limited stock is Sell, with an average 12-month price target of $—. In fiscal year 2024, Genetic Technologies Limited reported revenue of $9.7M and net income of -$12.0M. For detailed data — including Genetic Technologies Limited revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Genetic Technologies Limited (GNTLF) stock price is $1.00. The stock is traded on OTC under the ticker symbol GNTLF. The 52-week range is $1.00 – $1.00.